Number of Shares
21,000.00
Current Holdings Value*
$704,550.00
% of Portfolio
0.61%
Total Estimate Gain
$-39,560.00
% of Total Estimate Gain
-5.49%

Birchview Capital, LP's Xenon Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Birchview Capital, LP held 21,000.00 shares of Xenon Pharmaceuticals Inc(XENE), totaling $704,550.00. This investment constitutes 0.61% of their stock portfolio, and Birchview Capital, LP now holds 0.03% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.

The initial trade took place in 2022Q2. And since then Birchview Capital, LP has made 2 purchases of XENE, at an average price of $34.29, for a total of 21,000.00 shares. Based on historical transaction data and XENE's current price of $32.41, Birchview Capital, LP's estimated gain on his XENE holdings is $-39,560.00, reflecting a -5.49% gain to date.

Birchview Capital, LP XENE ($32.41) Holding Chart

Birchview Capital, LP XENE ($32.41) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1